---
title: "LifeStance Health | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 403.48 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285657510.md"
datetime: "2026-05-08T03:22:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285657510.md)
  - [en](https://longbridge.com/en/news/285657510.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285657510.md)
---

# LifeStance Health | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 403.48 M

Revenue: As of FY2026 Q1, the actual value is USD 403.48 M, beating the estimate of USD 386.12 M.

EPS: As of FY2026 Q1, the actual value is USD 0.04, beating the estimate of USD 0.0081.

EBIT: As of FY2026 Q1, the actual value is USD 24.08 M.

#### Revenue

LifeStance Health Group, Inc. reported Q1 2026 revenue of $403.5 million, marking a 21% increase year-over-year compared to $333.0 million in Q1 2025 . Total Revenue Per Visit (TRPV) was $163.5 in Q1 2026, up from $158.7 in Q1 2025 .

#### Operational Metrics

**Net Income:** Net income for Q1 2026 was $14.2 million, significantly up from $0.7 million in Q1 2025 .

**Income from Operations:** Income from operations for Q1 2026 was $22.3 million, compared to $1.6 million in Q1 2025 .

**Operating Costs:** Center costs, excluding depreciation and amortization, were $267.5 million in Q1 2026, compared to $223.2 million in Q1 2025 . General and administrative expenses were $100.3 million in Q1 2026, compared to $94.4 million in Q1 2025 . Depreciation and amortization was $13.3 million in Q1 2026, down from $13.8 million in Q1 2025 .

**Center Margin (Non-GAAP):** Center Margin for Q1 2026 was $135.9 million, or 33.7% as a percentage of revenue, compared to $109.8 million, or 33.0% in Q1 2025 .

**Adjusted EBITDA (Non-GAAP):** Adjusted EBITDA for Q1 2026 was $51.1 million, or 12.7% as a percentage of revenue, compared to $34.6 million, or 10.4% in Q1 2025 .

#### Cash Flow

**Operating Cash Flow:** Net cash provided by operating activities was $33.1 million in Q1 2026, a substantial improvement from net cash used in operating activities of -$3.1 million in Q1 2025 .

**Free Cash Flow:** Free Cash Flow was $22.3 million in Q1 2026, compared to -$10.3 million in Q1 2025 .

**Investing and Financing Activities:** Net cash used in investing activities was -$13.9 million in Q1 2026, while net cash used in financing activities was -$73.0 million .

**Cash and Cash Equivalents:** The company ended Q1 2026 with cash and cash equivalents of $194.8 million .

#### Unique Metrics and Capital Allocation

**Clinicians:** The total number of clinicians reached 8,349, an 11% increase year-over-year, with 309 net clinician additions in Q1 2026 .

**Visit Volumes:** Q1 2026 visit volumes increased by 18% year-over-year to 2.5 million .

**Capital Expenditures:** Capital expenditures for Q1 2026 were $11 million .

**Debt:** Net long-term debt was $263 million at the end of Q1 2026 .

**Strategic Investments:** LifeStance Health Group, Inc. opened 6 new centers and completed 2 tuck-in acquisitions during Q1 2026 . The company also repurchased $49.1 million of common stock .

#### Outlook / Guidance

For the full year 2026, LifeStance Health Group, Inc. raised its revenue guidance to $1,640 – $1,680 million, Center Margin to $547 – $571 million, and Adjusted EBITDA to $200 – $220 million . For Q2 2026, the company expects revenue between $405 – $425 million, Center Margin between $135 – $147 million, and Adjusted EBITDA between $50 – $60 million . These projections assume 20 to 30 new center openings for the full year .

### Related Stocks

- [LFST.US](https://longbridge.com/en/quote/LFST.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)
- [Hafnia’s Q1 2026 Financial Results Presentation to Be Held on 27 May 2026 | HAFN Stock News](https://longbridge.com/en/news/287014236.md)
- [Keysight Technologies Reports Second Quarter 2026 Results | KEYS Stock News](https://longbridge.com/en/news/286959830.md)